Susan T. Hager

Susan T. Hager

Corporate Officer/Principal at
National Investor Relations Institute
Health Technology
Commercial Services
Process Industries

Profile

Susan T.
Hager
is currently the Co-Chairman-GreenBio Task Force at Massachusetts Biotechnology Council and a Member at National Investor Relations Institute.
She was previously the Corporate Director at Real Chemistry, Inc., Head-Corporate & Investor Relations at Oncotelic Therapeutics, Inc., VP-Investor Relations & Corporate Communications at Coley Pharmaceutical Group, Inc., VP-Investor Relations & Corporate Communications at Targanta Therapeutics Corp., SVP-Corporate Communications & Government Affairs at PTTGC Innovation America Corp., VP-Corporate Communications & Government Affairs at Qteros, Inc., and Senior Manager-Global Communications at Bayer HealthCare.
She was also the SVP-Corporate Communications & Government Affairs at Foundation Medicine, Inc. from 2014 to 2019.
Ms. Hager received her undergraduate and MBA degrees from Northeastern University.

Susan T. Hager active positions

CompaniesPositionStart
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Susan T. Hager

CompaniesPositionEnd
FOUNDATION MEDICINE INC Public Communications Contact 2019-05-31
Public Communications Contact 2007-12-31
Corporate Officer/Principal -
Public Communications Contact -
Investor Relations Contact -
See the detail of Susan T. Hager's experience

Training of Susan T. Hager

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Process Industries

Consumer Services

Commercial Services

Process Industries

Commercial Services

Health Services

Health Services

Commercial Services

  1. Stock Market
  2. Insiders
  3. Susan T. Hager